News for BioSyent Inc. (RX.V)

MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directo…

**media[507446]**

MISSISSAUGA, Ontario, Dec. 16, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exch…

TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) — This press release is being disseminated as required by National Instrument 62-103 –

**media[471506]**

MISSISSAUGA, Ontario, Nov. 13, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the …

MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) …

MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board...

TORONTO, July 24, 2024 (GLOBE NEWSWIRE) — This press release is being disseminated as required by National Instrument 62-103 –

BioSyent Releases Financial Results for Q1 2024

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICES